Y-mAbs Therapeutics Inc (YMAB)
17.15
-0.10
(-0.58%)
USD |
NASDAQ |
May 03, 16:00
17.11
-0.04
(-0.23%)
After-Hours: 20:00
Y-mAbs Therapeutics Total Assets (Quarterly): 127.87M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 127.87M |
| September 30, 2023 | 128.88M |
| June 30, 2023 | 132.40M |
| March 31, 2023 | 137.44M |
| December 31, 2022 | 141.46M |
| September 30, 2022 | 143.92M |
| June 30, 2022 | 165.18M |
| March 31, 2022 | 191.05M |
| December 31, 2021 | 212.78M |
| September 30, 2021 | 239.98M |
| June 30, 2021 | 259.48M |
| March 31, 2021 | 274.92M |
| Date | Value |
|---|---|
| December 31, 2020 | 132.05M |
| September 30, 2020 | 143.20M |
| June 30, 2020 | 167.33M |
| March 31, 2020 | 194.07M |
| December 31, 2019 | 216.37M |
| September 30, 2019 | 103.68M |
| June 30, 2019 | 126.04M |
| March 31, 2019 | 140.00M |
| December 31, 2018 | 151.92M |
| September 30, 2018 | 166.39M |
| June 30, 2018 | 73.30M |
| December 31, 2017 | 92.13M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
103.68M
Minimum
Sep 2019
274.92M
Maximum
Mar 2021
170.43M
Average
143.92M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| The Cooper Companies Inc | 12.03B |
| Puma Biotechnology Inc | 230.53M |
| Humacyte Inc | 128.22M |
| Moderna Inc | 16.73B |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.88M |
| Shareholders Equity (Quarterly) | 100.98M |
| Current Ratio | 5.520 |